期刊文献+

肉毒毒素A治疗颈源性头痛的双盲研究 被引量:15

Treatment of cervicogenic headache with botulinum toxin A: a doable-blind trial
下载PDF
导出
摘要 目的:颈部骨骼肌源性头痛目前尚无治疗的有效方法,观察肉毒毒素A治疗颈部骨骼肌源性头痛的疗效。方法:采用双盲原则,将40例颈源性头痛患者随机分为治疗组和对照组,分别接受浓度为50 u/ml肉毒毒素A溶液和生理盐水颈部多个肌筋膜扳机点注射。结果:头痛情况采用头痛月天数和头痛指数进行评估,治疗组在治疗后两周、四周时头痛月天数(2.0±2.4,2.2±2.6)和头痛指数(2.5±3.5,3.5±3.6)明显减低,和对照组(14.6±5.2,16.1±5.2和24.2±14.1,26.3±11.2)及治疗前(14.7±5.8和32.6±19.6)差异均有显著性意义(P<0.01)。结论:肉毒毒素A颈部肌筋膜扳机点注射是治疗颈部骨骼肌源性头痛的有效方法。 AIM: To detennine whether therapy with botulinum toxin A may prove to be an effective treatment for headaches of musculo-skeletal origin. METHODS: According to double-blind principle, 40 patients suffering from cer-vicogenic headache were divided into the treatment group and the control group. Each member of the treatment group received liquor diluting botulinum toxin A(50 units/ml), while each member of the control group received a placebo dose consisting only of saline. RESULTS: At both 2 and 4 weeks post injection, the treatment group showed a statistically significant reduction in: (1) the number of headache days per month (2. 0±2.4, 2. 2±2. 6) and (2) the headache index(2. 5±3. 5, 3. 5±3. 6), as compared with either the control group(14. 6±5. 2, 16.1±5. 2 and 24.2±14.1, 26.3±11.2) ( P < 0. 01) or the pre-injection treatment group(14.7±5.8 and 32. 6±19.6) (P <0.01) .CONCLUSION: The injection of botulinum toxin A into myofacial trigger points is an effective treatment for headaches of musculo-skeletal origin.
出处 《中国临床康复》 CAS CSCD 2003年第2期260-261,共2页 Chinese Journal of Clinical Rehabilitation
关键词 肉毒毒素A 治疗 颈源性头痛 双盲法 扳机点 headache/therapy double-blind method botulinum toxin type A/therapeutic use
  • 相关文献

参考文献9

  • 1[2]Bogduk N.Cervicogenic headache:anatomic basis and pathophysiologic mechanisms.Curr Pain Headache Rep 2001;5(4):382- 6
  • 2[3]Silverman SB.Cervicogenic headache:interventional, anesthetic,and ablative treatment.Curr Pain Headache Rep 2002;6(4):308- 14
  • 3[4]Pan GY,Lu W.Inrestigations of three waysof curing cervical headache of chilalren.Zhongguo Linchuang Kangfu(Chin J clin Rehabil) 2002;6(16):2422
  • 4[5]Evers S,Rahmann A,Vollmer HJ,et al.Treatment of headache with botulinum toxin A a review according to evidence based medicine criteria.Cephalalgia 2002;22(9):699- 710
  • 5[6]Sjaastad O,Fredrilsen TA,Pfaffenrath V.Cervicogenic headache:cliagnostic criteria.The Cervicogenic Headache 1998;38(6):4425
  • 6[7]Tfelt Hansen P,Olesen J.Methodological aspects of drug trials in migraire.Neuroepidemidogy 1985;4(4):204- 26
  • 7[8]Simons DG,Hong CZ,Simons LS.Endplate potentials are common to midfiber myofacial trigger points.Am J Phys Med Rehabil 2002;81(3):212- 22
  • 8[9]Biondi DM.Cervicogenic headache:mechanisms,evaluation, and treatment strategies.J Am Osteopath Assoc 2000;100(9):7- 14
  • 9[10]Sun XM,Wu XL,Zhao HQ,Zhan SS,Zhang QY,Bao SR.Sffects of botulinum toxin A on the dystonia by various dosage of injection.Zhongguo Linchuang Kangfu(Chin J clin Rehabil) 2002;6(18):2701- 2

同被引文献202

引证文献15

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部